Long‐term use of proton pump inhibitors in GORD – help or hindrance?
- 1 September 2001
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 15 (s2) , 6-9
- https://doi.org/10.1046/j.1365-2036.2001.00115.x
Abstract
Many patients with gastro-oesophageal reflux disease (GORD) experience chronic relapses and require maintenance therapy for symptomatic relief. This article reviews possible mechanisms for chronic relapse in GORD, and discusses the risks and benefits of proton pump inhibtors as maintenance therapy for this disease. Recent medical literature was reviewed to gather information about proton pump inhibitor therapy and GORD. The reports indicated that the tendency to relapse in GORD is probably related to ongoing motor defects and to the acid rebound that follows sucessful healing therapy. Proton pump inhibitors are very effective in maintaining symptomatic and endoscopic remission in GORD. Limitations of proton pump inhibitor therapy have largely so far been clinically irrelevant. Most side-effects are inherent consequences of any form of acid suppression therapy, and include hypergastrinaemia and rebound hyperacidity upon discontinuation of therapy. We conclude that the therapeutic balance tips toward proton pump inhibitors for treatment of GORD because their limitations are largely surpassed by excellent clinical efficacy, tolerance, and lack of serious adverse effects.Keywords
This publication has 14 references indexed in Scilit:
- Lack of effect of acid suppression therapy on gastric atrophyGastroenterology, 1999
- Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg dailyAlimentary Pharmacology & Therapeutics, 1998
- Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitisAlimentary Pharmacology & Therapeutics, 1996
- Effective Maintenance Treatment of Reflux Esophagitis with Low-Dose LansoprazoleAnnals of Internal Medicine, 1996
- Atrophic Gastritis andHelicobacter pyloriInfection in Patients with Reflux Esophagitis Treated with Omeprazole or FundoplicationNew England Journal of Medicine, 1996
- Prognostic factors for relapse and maintenance treatment with cisapride in gastro-oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1995
- Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group.Gut, 1995
- Efficacy and safety of lansoprazole 15 mg oad or 30mg oad as one year maintenance treatment for erosive reflux esophagitis. A randomized trialGastroenterology, 1995
- Omeprazole or ranitidine in long-term treatment of reflux esophagitisGastroenterology, 1994
- Efficacy of Omeprazole in Lower Grades of Gastro-Oesophageal Reflux DiseaseScandinavian Journal of Gastroenterology, 1994